Protara Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Protara Therapeutics, Inc. (TARA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 1.06 million shares for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-08.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2025-05-08
- Protara Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-03-31 was 1.06M shares.
- Protara Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2019-12-31 was -1.15M shares.
- Protara Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2019-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- Protara Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2019-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- Protara Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 1.39M shares.
- Protara Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2019 was 29.56K shares, a 42.08% decline from fiscal 2018.
- Protara Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2018 was 51.04K shares, a 92.90% decline from fiscal 2017.
- Protara Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2017 was 719.34K shares, a 442.92% increase from fiscal 2016.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed |
|---|---|---|---|---|---|
| 2025-03-31 | 1.06M shares 10-Q · filed 2025-05-08 | ||||
| 2024-12-31 | 1.39M shares 10-K · filed 2025-03-05 | ||||
| 2019-12-31 | -1.15M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-20 | -1.15M shares derived: sum of 2 quarters · filed 2020-03-20 | -1.15M shares derived: sum of 3 quarters · filed 2020-03-20 | 29.56K shares 10-K · filed 2020-03-20 | |
| 2019-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | 0.00 shares derived: sum of 2 quarters · filed 2019-10-31 | 1.18M shares 10-Q · filed 2019-10-31 | -808.06K shares derived: sum of 4 quarters · filed 2020-03-20 | |
| 2019-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | 1.18M shares 10-Q · filed 2019-08-07 | -808.06K shares derived: sum of 3 quarters · filed 2020-03-20 | -658.06K shares derived: sum of 4 quarters · filed 2020-03-20 | |
| 2019-03-31 | 1.18M shares 10-Q · filed 2019-05-08 | -808.06K shares derived: sum of 2 quarters · filed 2020-03-20 | -658.06K shares derived: sum of 3 quarters · filed 2020-03-20 | -556.46K shares derived: sum of 4 quarters · filed 2020-03-20 | |
| 2018-12-31 | -1.99M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-20 | -1.84M shares derived: sum of 2 quarters · filed 2020-03-20 | -1.74M shares derived: sum of 3 quarters · filed 2020-03-20 | 51.04K shares 10-K · filed 2020-03-20 | 2.04M shares 10-K · filed 2019-03-13 |
| 2018-09-30 | 150.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | 251.60K shares derived: sum of 2 quarters · filed 2018-11-07 | 2.04M shares 10-Q · filed 2018-11-07 | 2.04M shares derived: sum of 4 quarters · filed 2019-03-13 | |
| 2018-06-30 | 101.60K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | 1.89M shares 10-Q · filed 2018-08-07 | 1.89M shares derived: sum of 3 quarters · filed 2019-03-13 | ||
| 2018-03-31 | 1.79M shares 10-Q · filed 2018-05-09 | 1.79M shares derived: sum of 2 quarters · filed 2019-03-13 | |||
| 2017-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | 719.34K shares 10-K · filed 2019-03-13 | |||
| 2017-09-30 | 719.34K shares 10-Q · filed 2017-11-07 | ||||
| 2016-12-31 | 132.50K shares 10-K · filed 2019-03-13 | ||||
| 2015-12-31 | 1.01M shares 10-K · filed 2018-03-14 | ||||
| 2014-12-31 | 132.15K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | 659.87K shares 10-K · filed 2017-03-16 | |||
| 2014-09-30 | 527.72K shares 10-Q · filed 2014-11-25 | ||||
| 2013-12-31 | 3.15K shares 10-K · filed 2016-03-14 | ||||
| 2012-12-31 | 0.00 shares 10-K · filed 2015-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |